Lipella Pharmaceuticals Inc. (NASDAQ: LIPO) Stock Information | RedChip

Lipella Pharmaceuticals Inc. (NASDAQ: LIPO)
Listen to this Section


$0.48
-0.0297 ( -5.85% ) 491.2K

Lipella Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is focused on developing new drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for new applications. The company's product candidates include LP-10, LP-310 and LP-410 which can be helpful in treatment of Hemorrahagic Cystitis, Oral Licen Planus and Oral Graft.

Market Data


Open


$0.48

Previous close


$0.51

Volume


491.2K

Market cap


$3.98M

Day range


$0.44 - $0.50

52 week range


$0.32 - $2.71

Insider Ownership Transactions

Total Amount Purchased: -359,906.00

Date Type Amount Purchased Purchaser
2024-05-15 Buy 10000.00 Kaufman Jonathan H
2024-03-19 Sale -25000.00 Pruchnic Ryan
2024-03-19 Sale -25000.00 Yoshimura Naoki
2024-03-19 Sale -80000.00 Chancellor Michael B
2024-03-19 Sale -25000.00 Birder Lori
2024-03-19 Buy 30000.00 Kaufman Jonathan H
2024-03-19 Sale -50000.00 Johnston Douglas
2024-03-19 Sale -25000.00 Cohen Daniel R
2024-03-19 Sale -25000.00 Kim Byong
2024-03-15 Sale -144906.00 Kaufman Jonathan H

SEC Fillings


Form Type Description Pages Date
4 Insider transactions 1 Mar 15, 2024
10-k Annual reports 77 Feb 27, 2024
8-k 8K-related 12 Dec 01, 2023
8-k 8K-related 12 Nov 28, 2023
8-k 8K-related 12 Nov 22, 2023
10-q Quarterly Reports 64 Nov 14, 2023
8-k 8K-related 19 Oct 26, 2023
def Proxies and info statements 4 Oct 10, 2023
8-k 8K-related 38 Sep 11, 2023
10-q Quarterly Reports 63 Aug 14, 2023

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.